(Q46792538)

25 December 2017

title

Absorption enhancement studies of clopidogrel hydrogen sulphate in rat everted gut sacs (English)

1 reference

25 December 2017

1 reference

Mohamed Ali Lassoued

1

1 reference

25 December 2017

Souad Sfar

series ordinal

2

1 reference

25 December 2017

Abderrahman Bouraoui

series ordinal

3

1 reference

25 December 2017

Fathia Khemiss

series ordinal

4

1 reference

25 December 2017

publication date

29 December 2011

1 reference

25 December 2017

Journal of Pharmacy and Pharmacology

published in

1 reference

25 December 2017

volume

64

1 reference

25 December 2017

issue

4

1 reference

25 December 2017

page(s)

541-552

1 reference

25 December 2017

Transporters in absorption, distribution, and elimination

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01434.X

Clopidogrel resistance: what's new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01434.X

Clinical, pharmacokinetic, and pharmacogenetic determinants of clopidogrel resistance in Korean patients with acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01434.X

Genetic determinants of response to clopidogrel and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01434.X

Impact of genetic polymorphisms and drug-drug interactions on clopidogrel and prasugrel response variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01434.X

The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01434.X

Drug delivery to the upper small intestine window using gastroretentive technologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01434.X

Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01434.X

Oral formulation strategies to improve solubility of poorly water-soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01434.X

Functional evaluation of ABCB1 (P-glycoprotein) polymorphisms: high-speed screening and structure-activity relationship analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01434.X

Drugs as P-glycoprotein substrates, inhibitors, and inducers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01434.X

Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01434.X

Effect of in vitro exposure to Vibrio vulnificus on hydroelectrolytic transport and structural changes of sea bream (Sparus aurata L.) intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01434.X

Improvement of solubility and dissolution rate of indomethacin by solid dispersions in Gelucire 50/13 and PEG4000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01434.X

Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01434.X

Strategies for absorption screening in drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01434.X

Maximising use of in vitro ADMET tools to predict in vivo bioavailability and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01434.X

Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01434.X

Improvement of intestinal absorption of P-glycoprotein substrate by D-tartaric acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01434.X

Modulating effect of polyethylene glycol on the intestinal transport and absorption of prednisolone, methylprednisolone and quinidine in rats by in-vitro and in-situ absorption studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01434.X

Mechanistic analysis for drug permeation through intestinal membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01434.X

The role of P-glycoprotein in limiting intestinal regional absorption of digoxin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01434.X

10.1111/J.2042-7158.2011.01434.X

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017